Global malaria eradication: Is it still achievable and practicable?

Journal of Malaria Research

Volumn 2, Issue 1, 2011, Pages 37-62

  Karunamoorthi, Kaliyaperumal ^a,b  

^a JIMMA UNIVERSITY   (Ethiopia)

^b BHARATHIAR UNIVERSITY   (India)

Author keywords

Antimalarials; Genetically modified mosquitoes; Malaria eradication; Repellent; Vaccines; Vector control

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ; CHLOROQUINE; CHLORPHENOTANE; DIETHYLTOLUAMIDE; INSECT REPELLENT; MALARIA VACCINE; PRIMAQUINE; RTS S; UNCLASSIFIED DRUG;

AFRICA; ANTIBIOTIC RESISTANCE; ARTICLE; ASIA; CHILDHOOD MORTALITY; HEALTH CARE PLANNING; HEALTH CARE SYSTEM; HEALTH PROGRAM; HUMAN; INCIDENCE; INDOOR RESIDUAL SPRAYING; INSECTICIDE RESISTANCE; LABORATORY DIAGNOSIS; MALARIA; MALARIA CONTROL; MALARIA FALCIPARUM; MATHEMATICAL MODEL; MORBIDITY; MORTALITY; MOSQUITO; NONHUMAN; PLASMODIUM VIVAX MALARIA; POLITICS; PUBLIC HEALTH; SOCIOECONOMICS; SOUTH AND CENTRAL AMERICA; TRANSGENIC ORGANISM; UNSPECIFIED SIDE EFFECT; VECTOR CONTROL;

EID: 84879804159     PISSN: 19395906     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (146)

1. M. Jacobs-lorena, and A. A. James, Genetic modification of insects of medical importance: past, present and future. Report of the Scientific Working Group on Insect Vectors and Human Health, TDR/SWG/VEC/03.1 P68-73.(2002)
2. K. Karunamoorthi and K. Ilango, Eur. Rev. Med. Pharmacol. Sci. 14(1), 57, (2010).
3. WHO. World Malaria Report 2009. The World Health Organization, Geneva, Switzerland (2009).
4. R. M. Packard, The making of a tropical disease: a short history of malaria. Baltimore: Johns Hopkins University Press (2007).
5. R. Butler, S. Khanand, E. Ferguson, J. R. Coll. Physicians Edinb. 40, 72, (2010).
6. G. Majori, The Lancet, 354, 31, (2000).
7. J. A. Nájera, M. González-Silva and P. L. Alonso, PLoS Med. 8(1), e1000412, (2011).
8. WHO. World Malaria Report 2008. The World Health Organization, Geneva, Switzerland (2008).
9. WHO. World Malaria Report 2005. http://rbm.who.int/wmr. (2005) (accessed on 31st December 2010).
10. K. Karunamoorthi, D. Bishaw and T. Yilkal, J. Pub. Health, 18, 559, (2010).
11. K. Karunamoorthi and M. Bekele, J. Infect. Pub. Health, 2(4), 171, (2009).
12. J. A. Berkley, P. Bejon, T. Mwangi, et al. Clin. Infect. Dis. 49, 336, (2009).
13. J. Crawley, C. Chu, G. Mtove and F. Nosten, The Lancet, 375, 1468 (2010).
14. B. Greenwood, Trans. R. Soc. Trop. Med.Hyg.103S, S2, (2009).
15. L. Roberts and M. Enserink, Science, 318, 1544, (2007).
16. Bill and Melinda Gates Foundation Malaria Forum - Day 2, 17 October 2007 [Transcript].
17. G. W. Fegan, A. M. Noor, W. S. Akhwale and S. Cousens, The Lancet, 370, 1035, (2007).
18. R. Feachem and O. Sabot, The Lancet, 371, 1633, (2008).
19. Wernsdorfer. Historical review of the global malaria eradication program - Concept, achievements, shortcomings. Presentation at WHO Informal Consultation on Global Malaria Control and Elimination, (2008).
20. WHO. Global malaria control and elimination: report of a technical review. Global Malaria Control and Elimination Meeting (2008). http://malaria.who.int/docs/elimination/MalariaControlEliminationMeeting.pdf
21. Editorial, The Lancet, 370, 1459, (2007).
22. WHO. Malaria Control in Countries where Time-limited Eradication is Impracticable at Present: Technical Report Series 537. Geneva, Switzerland, (1974).
23. WHO. Re-examination of the global strategy of malaria eradication. Geneva: World Health Organization. Geneva, Switzerland, (1969).
24. S. I. Hay, C. A. Guerra, A. J. Tatem, A. M. Noor and R. W. Snow, Lancet Infect. Dis. 4, 327, (2004).
25. C. A. Guerra, P. W. Gikandi, A. J. Tatem, et al., PLoS Med. 5, e38, (2008).
26. Kleinschmidt, C. Schwabe, L. Benavente, et al., Am. J. Trop. Med.Hyg.80: 882 (2009).
27. R. G. A. Feachem, A. A. Phillips, J. Hwang, et al., The Lancet, (2010).
28. P. Das and R. Horton, Malaria elimination: worthy, challenging, and just possible. The Lancet, 376, 1515 (2010).
29. W. Kilama and F. Ntoumi, The Lancet, 374, 1480, (2009).
30. L. Molineaux and G. Gramiccia, The Garki Project. Geneva: World Health Organization. 311p, (1980).
31. G. F. Killeen, T. A. Smith, H. M. Ferguson, S. Abdulla, H. Mshinda, et al., PLoS Med. 4, e229, (2007). doi:10.1371/journal.pmed.0040229.
32. C. Lengeler, Cochrane Database Syst. Rev. CD000363, (2004). doi:10.1002/14651858.CD000363.pub2.
33. B. L. Sharp, I. Kleinschmidt, E. Streat, R. Maharaj, K. I. Barnes, et al., Am. J. Trop. Med. Hyg. 76, 42, (2007).
34. D. L. Smith, J. Dushoff, R. W. Snow and S. I. Hay, Nature, 438, 492, (2005).
35. D. L. Smith, F. E. McKenzie, R. W. Snow and S. I. Hay, PLoS Biol. 5, e42, (2007).
36. G. F. Killeen, A. Tami, J. Kihonda, F. O. Okumu, M. E. Kotas, et al., BMC Infect. Dis. 7, 121, (2007).
37. D. A. Henderson, Smallpox: the death of a disease. New York: Prometheus Books, (2009).
38. J. Tatem, D. L. Smith, P. W. Gething, C. W. Kabaria, R. W. Snow and S. I. Hay, Lancet, 2010; published online Oct 29. DOI:10.1016/S0140-6736(10)61301-3.
39. The malERA Consultative Group on Modeling, PLoS Med. 8, e1000403, (2011).
40. F. H. Osier, G. Fegan, S. D. Polley, L. Murungi, F. Verra, et al., Infect. Immun. 76, 2240, (2008).
41. P. D. Crompton, M. A. Kayala, B. Traore, K. Kayentao, A. Ongoiba, et al., Proceed. Natl. Acad. Sci. USA, 107, 6958, (2010).
42. K. Karunamoorthi, Clin. Microbiol. Infect. (In Press). (2011).
43. K. Karunamoorthi and S. Sabesan, Parasitol. Res. 105(3), 641, (2009).
44. K. Kaliyaperumal and D. Yesuf, East Afr. J. Pub. Health, 6(2), 205, (2009).
45. Enayati and J. Hemingway, Ann. Rev. Entomol. 55, 569, (2010).
46. W. K. Reisen and P. F. L. Boreham, J. Med. Entomol. 19, 98, (1982).
47. J. Hill, J. Lines and M. Rowland, Adv. Parasitol. 61, 77, (2006).
48. WHO. Malarial and HIV/AIDS interactions and policy implications. Report of an informal technical consultation, 23-25 June 2004. WHO/HIV/2004.8 Geneva, Switzerland. (2004).
49. C. Lengeler, Insecticide-treated bednets and curtains for preventing malaria (Cochrane Review). The Cochrane Library. Oxford: Update Software. (2002).
50. B. Adele, The Lancet, 374, 1581, (2009).
51. W. A. Hawley, P. A. Phillips-Howard, F. O. terKuile, D. J. Terlouw, J. M. Vulule, M. Ombok, B. L. Nahlen, J. E. Gimnig, S. K. Kariuki, M. S. Kolczak and A. W. Hightower, Am. J. Trop. Med. Hyg. 68(4S), 121, (2003).
52. Roll Back Malaria. World malaria day 2010: Africa update. Progress and impact series. (2010).
53. C. Lengeler, Cochrane Database Syst. Rev. 2, CD000363. (2004).
54. C. Lengeler and B. Sharp, Indoor residual spraying and insecticide-treated nets. In: C. Murphy, K. Ringheim, S. Woldehanna and J. Volmink. eds. Reducing malaria's burden: evidence of effectiveness for decision makers. Washington, DC: Global Health Council, 17-24. (2003).
55. J. Etang, F. Chandre, P. Guillet and L. Manga, Malar. J. 3, 46, (2004).
56. WHO. Global Malaria Programme. Indoor residual spraying Use of indoor residual spraying for scaling up global malaria control and elimination. Geneva, Switzerland. (2006).
57. H. Ranson, H. Abdallah, A. Badolo, W. M. Guelbeogo, C. Kerah-Hinzoumbé, et al., Malar. J. 8, 299, (2009).
58. WHO. WHO. Tech. Rep. Ser. 125, (1957).
59. USAID. Integrated Vector Management Programs for Malaria Control. Programmatic Environmental Assessment. (2007).
60. V. Corbel, R. N'Guessan, C. Brengues, et al., Acta Trop. 101, 207, (2007).
61. K. Karunamoorthi and S. Sabesan, Eur. Rev. Med. Pharmacol. Sci. 14(5), 443, (2010).
62. Moore and RITAM Vector Control Group, Guidelines for Studies on Plant-based Insect Repellents. CRC Press LLC, p. 366, (2004).
63. K. Karunamoorthi and S. Sabesan, Int. Health, 1(2), 173, (2009).
64. R. P. Moody, F. M. Benoit, R. Riedel and L. J. Ritter, Toxicol. Environ. Health, 26, 137, (1989).
65. J. R. Clem, D. F. Havemann and M. A. Raebel, Ann. Pharmacother, 27, 289, (1993).
66. J. Zhu, X. Zeng, L. T. Yanma, K. Qian, Y. Han, S. Xue, B. Tucker, G. Schultz, J. Coats, W. Rowley and A. Zhang, J. Am. Mosq. Control. Assoc. 22(3), 515, (2006).
67. V. I. Vashkov, S. E. Gleiberman and A. P. Volkova, Med. Parazitol. Bolezni. 45(6), (1976).
68. B. Gerhardson, Trends Biotechnol. 20, 338, (2002).
69. V. P. Sharma and M. A. Ansari, Indian J. Med. Entomol. 31(3), 505, (1994).
70. V. P. Sharma, B. N. Nagpal and A. Srivastava, Trans. R. Soc. Trop. Med. Hyg. 87, 627, (1993).
71. K. Karunamoorthi, S. Ramanujam and R. Rathinasamy, Parasitol. Res. 103(3), 545, (2008).
72. K. Karunamoorthi, K. Ilango and A. Endale, J. Ethnopharmacol. 125(2), 224, (2009).
73. G. Harrison, Mosquitoes, malaria, and man: a history of the hostilities since 1880. New York: EP Dutton, (1978).
74. WHO, WHO Global Malaria Programme: Q and A on malaria elimination and eradication. (2010).
75. C. Cross, Malaria is diagnosed using a combination of clinical observations, case history and diagnostic tests. (2004). http://malaria.wellcome.ac.uk/doc_WTD023886.html.
76. C. Wongsrichanalai, I. Arevalo, A. Laoboonchai, K. Yingyuen, R. S. Miller, A. J. Magill, J. R. Forney and R. A. Gasser Jr, Am. J. Trop. Med. Hyg. 69, 26, (2003).
77. The malERA Consultative Group on Drugs. PLoS Med. 8(1), e1000402, (2011).
78. G. Lewison and D. Srivastava, Acta Trop. 106, 96, (2008).
79. M. Mayxay, S. Pukritrayakamee, K. Chotivanich, M. Imwong, S. Looareesuwan and N. J. White, Am. J. Trop. Med. Hyg. 65, 588, (2001).
80. S. Krudsood, P. Wilairatana, D. P. Mason, S. Treeprasertsuk, P. Singhasivanon, and S. Looa-reesuwan, Southeast Asian J. Trop. Med. Pub. Health, 30, 623, (1999).
81. V. Wiwanitkit, J. Vector Borne Dis. 45, 98, (2008).
82. S. Yeung, W. Pongtavornpinyo, I. M. Hastings, A. J. Mills, and N. J. White, Am. J. Trop. Med. Hyg. 71, 179, (2004).
83. P. G. Kremsner, and S. Krishna, The Lancet, 364, 285, (2004).
84. Editorial, BMJ, 331, 706, (2005). doi: 10.1136/bmj.331.7519.706.
85. M. Dondorp, F. Nosten, Y. Poravuth, et al., N. Engl. J. Med. 361, 455, (2009).
86. T. A. Wells, A question of quality: interview with Chris Hentschel, President and CEO of MMV. October, 2008. http://www.mmv.org/IMG/pdf/FINAL_mmv08_news17_A4pgs.pdf.
87. P. N. Newton, R. McGready, F. Fernandez, M. D. Green, M. Sunjio, C. Bruneton, S. Phanouvong, P. Millet, C. J. Whitty, A. O. Talisuna, S. Proux, E. M. Christophel, G. Malenga, P. Singhasivanon, K. Bojang, H. Kaur, K. Palmer, N. P. Day, B. M. Greenwood, F. Nosten and N. J. White, PLoS Med. 3, e197, (2006).
88. P. Newton, S. Proux, M. Green, F. Smithuis, J. Rozendaal, S. Prakongpan, K. Chotivanich, M. Mayxay, S. Looareesuwan, J. Farrar, F. Nosten and N. J. White, Lancet, 357, 1948, (2001).
89. L. Cui, et al., Acta Trop. (2011). Doi:10.1016/j.actatropica.2011.04.006.
90. F. M. Snowden, The conquest of malaria. Italy 1900-1962. New Haven: Yale University Press. (2005).
91. L. J. Bruce-Chwatt, Bull. World Health Organ. 21, 737, (1959).
92. Kaneko, G. Taleo, M. Kalkoa, S. Yamar, T. Kobayakawa, et al., Lancet, 356, 1560, (2000).
93. MMV. Medicines for Malaria Venture. Understanding the antimalarials market: Uganda 2007-an overview of the supply side. Nov 6, 2008. http://www.mmv.org/article.php3?id_article=536.
94. ACT watch. http://www.actwatch.info/home/home.asp (accessed Oct 12, 2010).
95. L. J. Bruce-Chwatt, et al., Chemotherapy of malaria, Geneva, World Health Organization, (1986).
96. H. O. Lobel and C. C. Campbell, Clin. Trop. Med. Commun. Dis. 1, 225, (1986).
97. P. B. Bloland, Drug resistance in malaria. WHO/CDS/CSR/DRS/2001.4, (2001).
98. D. N. Nabarro and E. M. Talyer, Science, 280, 2067, (1998).
99. M. Enserink, Malaria's drug miracle in danger. Science. pp. 844, (2010).
100. N. J. White, Lancet, 376, 2051, (2010).
101. C. Wongsrichanalai and S. R. Meshnick, Emerg. Infect. Dis. 14, 716, (2008).
102. J. F. Cortese, A. Caraballo, C. E. Contreras and C. V. Plowe, J. Infect. Dis. 186, 999, (2002).
103. M. M. Nyunt and C. V. Plowe, Clin. Pharmacol. Ther. 82, 601, (2007).
104. WHO. Global Report on Antimalarial Drug Efficacy and Drug Resistance: 2000-2010. Geneva: WHO, (2010).
105. D. A. Henderson, Bull. World Health Organ. 65, 535, (1987).
106. J. John, Expert. Rev. Vaccines, 8, 5, (2009).
107. W. J. Moss and D. E. Griffin, Nat. Rev. Microbiol. 12, 900, (2006).
108. J. G. Breman, C. A. de Quadros, W. R. Dowdle, W. H. Foege, D. A. Henderson, et al., PLoS Med. 8, e1000405, (2011).
109. The malERA Consultative Group on Vaccines. PLoS Med, 8(1), e1000398, (2011).
110. UNDP/World Bank/WHO (TDR). Malaria transmission blocking vaccines: an ideal public good. TDR/RBM/MAL/VAC/2000.1. (2001).
111. J. L. Cole-Tobian, P. Michon, M. Biasor, et al., Infect. Immun. 77, 4009, (2009).
112. D. Butler, Nature, 462, 19. (2009).
113. Saul and M. P. Fay, PLoS One, 2, e850, (2007).
114. Malaria Vaccine Technology Roadmap Final Report (2006) Available: http://www.malariavaccineroadmap.net.
115. WHO. Malaria transmission blocking vaccines: An ideal public good. Geneva: World Health Organization. (2000) Available: http://www.who.int/vaccine_research/feuille_1_4-1pdf.
116. R. Carter, Vaccine, 19, 2309, (2001).
117. Y. Wu, R. D. Ellis, D. Shaffer, et al., PLoS One, 3, e2636, (2008).
118. R. R. Dinglasan and M. Jacobs-Lorena, Trends Parasitol. 24, 364, (2008).
119. PATH Malaria Vaccine Initiative: The PATH Malaria Vaccine Initiative [fact sheet]. Seattle: PATH; 2010. [http://www.malariavaccine.org//files/March182011MVIfactsheet_backgrounder.pdf]
120. K. P. Asante, S. Abdulla, S. Agnandji, J. Lyimo, J. Vekemans, S. Soulanoudjingar, R. Owusu and et al., Safety, immunogenicity and efficacy of the RTS,S/AS01E malaria vaccine candidate integrated in EPI: extended follow-up of a randomized controlled Phase 2 infant trial in Gabon, Ghana and Tanzania. Presented at: 59th annual meeting of the American Society of Tropical Medicine and Hygiene, Atlanta; November 5, (2010).
121. D. I. Ojakaa, P. Ofwar, Y. W. Machira, E. Yamo, Y. Collymore, A. Ba-Nguz, P. Vansadia and A. Bingham, Malar. J. 10, 147, (2011).
122. M. Jacobs-Lorena. J. Vect. Borne Dis. 40, 73, (2003).
123. Ghosh, M. J. Edwards and M. Jacobs-Lorena, Parasitol. Today 16, 196, (2000).
124. L. A. Moreira and M. Jacobs-Lorena, Neotrop. Entomol. 32(4), 531, (2003).
125. D. A. Amenya, M. Bonizzoni, A. T. Isaacs, N. Jasinskiene, H. Chen, O. Marinotti, G. Yan and AA. James, Insect Mol. Biol. 19(2), 263, (2010).
126. WHO. Progress and prospects for the use of genetically modified mosquitoes to inhibit disease transmission. World Health Organization, Geneva, Switzerland, 4-6 May 2009.
127. Ayyub. Risk analysis in engineering and economics. Boca Raton, USA, Chapman and Hall/CRC, (2002).
128. V. Dyck, J. Hendrichs and A. Robinson, eds. Sterile insect technique: principles and practice in area-wide integrated pest management. Dordrecht, Springer, (2005).
129. E. Knipling, J. Econ. Entomol. 48, 459, (1955).
130. L. Alphey. Population suppression strategies for dengue virus vector control (Aedes). Progress and prospects for the use of genetically modified mosquitoes to inhibit disease transmission. World Health Organization, Geneva, Switzerland, 4-6 May 2009.
131. M. Q. Benedict and A. S. Robinson, Trends Parasitol. 19, 349, (2003).
132. W. Klassen and C. Curtis. History of the sterile insect technique, In: V. Dyck, J. Hendrichs, A. Robinson, eds. Sterile insect technique: principles and practice in area-wide integrated pest management. Dordrecht, Springer, pp 53, (2005).
133. C. Lofgren, et al., Am. J. Trop. Med. Hyg. 23, 288, (1974).
134. H. Laven, Nature, 216, 383, (1967).
135. S. Dobson, C. Fox and F. Jiggins, Proceed. R. Biol. Soc. 269, 437, (2002).
136. C. Brelsfoard, Y. Sechan and S. Dobson, PLoS Negl. Trop. Dis. 2, e129, (2008).
137. Benedict. Conventional sterile insect technique against Anopheles arabiensis. Progress and prospects for the use of genetically modified mosquitoes to inhibit disease transmission. World Health Organization, Geneva, Switzerland. (2009).
138. M. H. Andreasen and C. F. Curtis, Med. Vet. Entomol. 19, 238, (2005).
139. M. Helinski, A. Parker and B. Knols, Malar. J. 5, 41, (2006). doi:10.1186/1475-2875-5-41.
140. B. G. J. Knols, H. C. Bossin, W. R. Mukabana and A. S. Robinson, Am. J. Trop. Med. Hyg. 77(6), 232, (2007).
141. S. P. Sinkins and F. Gould, Nat. Rev. Genet. 7, 427, (2006).
142. O. Terenius, O. Marinotti, D. Sieglaff and A. A. James, Cell Host Microbe. 13: 417, (2008).
143. M. Tanner and D. de Savign. Malaria eradication back on the table. http://www.who.int/bulletin/volumes/86/2/07-050633/en/ (accessed on 2nd June 2011).
144. The malERA Consultative Group on Basic Science and Enabling Technologies. PLoS Med. 8(1), e1000399. (2011).
145. Roll Back Malaria Partnership (2008). The global malaria action plan for a malaria free world. Geneva: RBM, Available: http://www.rollbackmalaria.org/gmap/gmap.pdf.
146. K. Mendis, A. Rietveld, M. Warsame, A. Bosman, B. Greenwood, et al., Trop. Med. Int. Health, 14, 802, (2009).